VTN and preeclampsia: The involvement of complement proteins in preeclampsia and HELLP syndrome is now apparent, but additional research is needed to understand how the complement protein biomarkers and complement genetic variations might be used therapeutically, to assist illness prediction, diagnosis, and therapy [39].